Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Misawa S, Sato Y, Katayama K, Nagashima K, Aoyagi R, Sekiguchi Y, Sobue G, Koike H, Yabe I, Sasaki H, et al. Lancet Neurol. 2016 Aug 2. PMID: 27496680. Abstract CommentRecommendBookmarkWatch